What is VERO's earnings growth forecast for 2026-2026?
(NASDAQ: VERO) Venus Concept's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Venus Concept's earnings in 2026 is -$54,614,000.
In 2026, VERO is forecast to generate -$8,685,079 in earnings, with the lowest earnings forecast at -$8,344,488 and the highest earnings forecast at -$8,940,523.
What is VERO's revenue growth forecast for 2026-2026?
(NASDAQ: VERO) Venus Concept's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Venus Concept's revenue in 2026 is $58,876,000.
In 2026, VERO is forecast to generate $124,776,899 in revenue, with the lowest revenue forecast at $119,883,688 and the highest revenue forecast at $128,446,808.
What is VERO's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: VERO) forecast ROA is -14.09%, which is lower than the forecast US Medical Devices industry average of 10.02%.
What is VERO's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: VERO) Venus Concept's current Earnings Per Share (EPS) is -$42.82. In 2026, VERO's EPS is forecast to hit -$4.67 (min: -$4.49, max: -$4.81).
What is VERO's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: VERO) forecast ROE is -392.63%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.